X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1449) 1449
Publication (128) 128
Newsletter (30) 30
Newspaper Article (27) 27
Book Review (20) 20
Book Chapter (16) 16
Book / eBook (8) 8
Magazine Article (5) 5
Conference Proceeding (3) 3
Dissertation (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1237) 1237
male (1142) 1142
hypogonadism (845) 845
index medicus (831) 831
testosterone (653) 653
middle aged (602) 602
adult (591) 591
aged (491) 491
risk factors (401) 401
testosterone - blood (397) 397
endocrinology & metabolism (393) 393
hypogonadism - epidemiology (385) 385
urology & nephrology (319) 319
prevalence (315) 315
female (314) 314
men (302) 302
erectile dysfunction (256) 256
adolescent (218) 218
hypogonadism - complications (213) 213
hypogonadism - drug therapy (212) 212
testosterone - therapeutic use (211) 211
metabolic syndrome (210) 210
late-onset hypogonadism (204) 204
androgens (203) 203
hypogonadism - blood (193) 193
older men (189) 189
research (172) 172
testosterone - deficiency (155) 155
young adult (154) 154
aged, 80 and over (152) 152
cross-sectional studies (150) 150
androgen deficiency (141) 141
hypogonadism - diagnosis (140) 140
obesity (139) 139
analysis (132) 132
diagnosis (131) 131
care and treatment (130) 130
health aspects (130) 130
hormone replacement therapy (129) 129
retrospective studies (129) 129
hypogonadism - etiology (126) 126
serum testosterone (125) 125
epidemiology (124) 124
comorbidity (123) 123
diabetes (123) 123
middle-aged men (121) 121
medicine & public health (120) 120
erectile dysfunction - epidemiology (119) 119
hormones (119) 119
aging (117) 117
hypogonadotropic hypogonadism (117) 117
hormone-binding globulin (114) 114
hypogonadism - physiopathology (111) 111
osteoporosis (110) 110
bone-mineral density (109) 109
impotence (109) 109
mortality (109) 109
andrology (108) 108
body mass index (108) 108
insulin-resistance (105) 105
medicine, general & internal (103) 103
endocrinology (100) 100
age factors (99) 99
therapy (98) 98
replacement therapy (96) 96
child (94) 94
prostate cancer (94) 94
surveys and questionnaires (92) 92
risk (90) 90
elderly-men (89) 89
abridged index medicus (87) 87
age (86) 86
bone density (85) 85
incidence (85) 85
risk-factors (83) 83
testosterone replacement therapy (82) 82
association (81) 81
cohort studies (78) 78
erectile dysfunction - etiology (77) 77
women (77) 77
luteinizing hormone - blood (75) 75
body-composition (73) 73
case-control studies (73) 73
sexual dysfunction (73) 73
androgens - therapeutic use (72) 72
quality-of-life (72) 72
insulin resistance (70) 70
physiological aspects (69) 69
aging - physiology (68) 68
disease (68) 68
low serum testosterone (68) 68
metabolic syndrome - epidemiology (68) 68
quality of life (68) 68
testosterone - administration & dosage (68) 68
treatment outcome (68) 68
cancer (66) 66
urology (66) 66
cardiovascular diseases - epidemiology (65) 65
prospective studies (65) 65
age of onset (63) 63
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1453) 1453
German (21) 21
French (18) 18
Spanish (13) 13
Russian (6) 6
Polish (5) 5
Chinese (4) 4
Hebrew (2) 2
Italian (2) 2
Japanese (2) 2
Portuguese (2) 2
Czech (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica, ISSN 0390-6078, 10/2004, Volume 89, Issue 10, pp. 1187 - 1193
Journal Article
Hormone Research in Paediatrics, ISSN 1663-2818, 07/2010, Volume 74, Issue 2, pp. 121 - 128
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 04/2010, Volume 95, Issue 4, pp. 1810 - 1818
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 03/2018, Volume 464, Issue C, pp. 4 - 13
Journal Article
Journal of Diabetes and Its Complications, ISSN 1056-8727, 2012, Volume 26, Issue 2, pp. 141 - 147
Abstract Context Evidence suggests that numerous comorbid conditions contribute to erectile dysfunction (ED) among patients with type 2 diabetes mellitus... 
Endocrinology & Metabolism | Erectile dysfunction | Diabetes | Comorbidity | Primary care | Sexual dysfunction | RISK-FACTORS | WEIGHT-LOSS | SMOKING | PREVALENCE | OBESITY | INSULIN-RESISTANCE | MEN | ENDOCRINOLOGY & METABOLISM | QUALITY-OF-LIFE | TESTOSTERONE DEFICIENCY | Prevalence | Dyslipidemias - complications | Obesity - psychology | Erectile Dysfunction - psychology | Humans | Diabetes Complications - psychology | Male | Erectile Dysfunction - epidemiology | Atherosclerosis - epidemiology | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Dyslipidemias - psychology | Hypogonadism - epidemiology | Erectile Dysfunction - drug therapy | Diabetes Complications - epidemiology | Phosphodiesterase 5 Inhibitors - therapeutic use | Hypertension - epidemiology | Smoking - psychology | Diabetes Mellitus, Type 2 - complications | Metabolic Syndrome - epidemiology | Metabolic Syndrome - psychology | Diabetes Mellitus, Type 2 - psychology | Depression - epidemiology | Hypogonadism - psychology | Obesity - complications | Risk Factors | Atherosclerosis - complications | Erectile Dysfunction - etiology | Diabetes Complications - complications | Metabolic Syndrome - complications | Dyslipidemias - epidemiology | Hypertension - psychology | Smoking - epidemiology | Weight Loss | Obesity - epidemiology | Atherosclerosis - psychology | Depression - psychology | Hypogonadism - etiology | Type 2 diabetes | Insulin resistance | Impotence | Sexual disorders | Endothelium
Journal Article
Medical Journal of Australia, ISSN 0025-729X, 01/2008, Volume 188, Issue 2, pp. 72 - 75
Objective: To evaluate the management, clinical outcomes and adherence to chelation therapy in adult transfusion‐dependent patients with thalassaemia major.... 
Hematologic diseases | SURVIVAL | MEDICINE, GENERAL & INTERNAL | COMPLICATIONS | DEFEROXAMINE | IRON-CHELATING THERAPY | Thalassemia - therapy | Erythrocyte Transfusion - adverse effects | Age Factors | Outcome Assessment (Health Care) | Humans | Middle Aged | Deferoxamine - therapeutic use | Hepatitis B - epidemiology | Male | Hypogonadism - epidemiology | Ferritins - blood | Time Factors | Hepatitis C - epidemiology | Siderophores - therapeutic use | Adult | Female | Hypothyroidism - epidemiology | Retrospective Studies | Iron Chelating Agents - therapeutic use | Thalassemia - epidemiology | Australia - epidemiology | Cardiomyopathies - epidemiology | Drug Prescriptions - statistics & numerical data | Diabetes Mellitus - epidemiology | Pyridones - therapeutic use | Patient Compliance | Outpatient Clinics, Hospital | Hepatitis C, epidemiology | Pyridones, therapeutic use | Thalassemia, epidemiology | Erythrocyte Transfusion, adverse effects | Iron Chelating Agents, therapeutic use | Deferoxamine, therapeutic use | Hepatitis B, epidemiology | Ferritins, blood | Hypothyroidism, epidemiology | Erythrocyte Transfusion | Prescriptions, Drug, statistics and numerical data | Diabetes Mellitus, epidemiology | Hypogonadism, epidemiology | Siderophores, therapeutic use | Thalassemia, therapy | Cardiomyopathies, epidemiology | Australia, epidemiology | Care and treatment | Patient outcomes | Thalassemia | Adults | Research | Health aspects | Chelation therapy
Journal Article
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 20, pp. 4057 - 4065
BACKGROUND Testicular cancer survivors (TCS) have an increased risk of treatment‐related cardiovascular disease (CVD), which may limit their overall survival.... 
atherosclerosis | high‐intensity interval training | risk factors | exercise therapy | biomarkers | testicular neoplasms | cardiovascular diseases | high-intensity interval training | MORTALITY | STATEMENT | DIAGNOSIS | METAANALYSIS | PREVENTION | FLOW-MEDIATED DILATION | EXERCISE | CHEMOTHERAPY | ONCOLOGY | ASSOCIATION | THICKNESS | High-Intensity Interval Training - methods | Testicular Neoplasms - rehabilitation | Humans | Middle Aged | Male | Testicular Neoplasms - epidemiology | Exercise Therapy | Young Adult | Exercise Test | Hypogonadism - epidemiology | Cardiovascular Diseases - epidemiology | Adult | Physical Fitness | Lipoproteins, LDL - metabolism | Parasympathetic Nervous System - physiopathology | Metabolic Syndrome - epidemiology | Cardiovascular Diseases - physiopathology | Prehypertension - epidemiology | Cardiovascular Diseases - metabolism | Comorbidity | Oxygen Consumption | Survivors | Carotid Artery Diseases - epidemiology | Inflammation | Obesity - epidemiology | Vascular Stiffness - physiology | Complications and side effects | Cancer patients | Care and treatment | Cardiovascular diseases | Testicular cancer | Risk factors | Identification methods | Clinical trials | Nervous system | Cardiovascular disease | Activation | Training | Confidence intervals | Randomization | Exercise | Covariance | Atherosclerosis | Stiffness | Mortality | Health risks | Risk analysis | Aerobics | Disease control | Survival | Morbidity | Luminous intensity | Physical fitness | Arteriosclerosis | Biomarkers | Sampling methods | Testes | Health risk assessment | Parasympathetic nervous system | Cancer | Long-term effects | Fitness
Journal Article
The Journal of Sexual Medicine, ISSN 1743-6095, 09/2012, Volume 9, Issue 9, pp. 2438 - 2447
While previous studies have noted that hypogonadism (HG) may pose a significant economic and quality‐of‐life burden, no studies have evaluated the impact of HG... 
Cost of Illness | Economic and Quality of Life Burden | Testosterone Deficiency | Hypogonadism | Resource Use | ANDROGEN DEFICIENCY | OPIOIDS | UROLOGY & NEPHROLOGY | OLDER MEN | PREVALENCE | TESTOSTERONE THERAPY | Office Visits - statistics & numerical data | Hypogonadism - drug therapy | United States - epidemiology | HIV Infections - epidemiology | Humans | Middle Aged | Sick Leave - statistics & numerical data | Hospitalization - statistics & numerical data | Neck Pain - epidemiology | Male | Absenteeism | Sick Leave - economics | Case-Control Studies | Hyperlipidemias - epidemiology | Hypogonadism - economics | Hypogonadism - epidemiology | Employment | Adult | Androgens - therapeutic use | Androgens - economics | Phosphodiesterase 5 Inhibitors - therapeutic use | Retrospective Studies | Hypertension - epidemiology | Emergency Service, Hospital - utilization | Insurance, Health | Testosterone - therapeutic use | Mental Disorders - epidemiology | Comorbidity | Testosterone - economics | Antihypertensive Agents - therapeutic use | Antidepressive Agents - therapeutic use | Drug Prescriptions - statistics & numerical data | Diabetes Mellitus - epidemiology | Obesity - epidemiology | Back Pain - epidemiology | Hypolipidemic Agents - therapeutic use | Hypertension | Drugs | Prescribing | Testosterone | Workers | Immunodeficiency | Health aspects | Disability insurance | Medical care, Cost of | Economics | Health care | Demography | Classification | Disabilities | Age | Morbidity | Quality of life
Journal Article
Journal Article
by Bonomi, Marco and Vezzoli, Valeria and Krausz, Csilla and Guizzardi, Fabiana and Vezzani, Silvia and Simoni, Manuela and Bassi, Ivan and Duminuco, Paolo and Di Iorgi, Natascia and Giavoli, Claudia and Pizzocaro, Alessandro and Russo, Gianni and Moro, Mirella and Fatti, Letizia and Ferlin, Alberto and Mazzanti, Laura and Zatelli, Maria Chiara and Cannavò, Salvo and Isidori, Andrea M and Pincelli, Angela Ida and Prodam, Flavia and Mancini, Antonio and Limone, Paolo and Tanda, Maria Laura and Gaudino, Rossella and Salerno, Mariacarolina and Francesca, Pregnolato and Maghnie, Mohamad and Maggi, Mario and Persani, Luca and Aimaretti, G and Altobell, M and Ambrosio, M.R and Andrioli, M and Angelett, G and Arecco, F and Arnald, G and Arosio, M and Balsamo, A and Baldassarr, M and Bartalena, L and Bazzon, N and Beccari, L and Beck-Peccoz, P and Bellastella, G and Bellizz, M and Benedicent, F and Bernasconi, S and Bizzarri, C and Bona, G and Bonadonna, S and Borrett, G and Boschetti, M and Brunani, A and Brunelli, V and Buz, F and Cacciatore, C and Cangiano, B and Cappa, M and Casalone, R and Cassio, A and Cavarzere, P and Cherubini, V and Ciampani, T and Cicognan, D and Cignarell, A and Cisternin, M and Colombo, P and Corbetta, S and Corciul, N and Corona, G and Cozzi, R and Crivellaro, C and Dalle Mule, I and Danesi, L and Eli, A.V.D and Degli Uberti, E and De Leo, S and Della Valle, E and De Marchi, M and Di Iorgi, N and Di Mambr, A and Fabbri, A and Foresta, C and Forti, G and Franceschi, A.R and Garolla, A and Ghezzi, M and Giacomozzi, C and Giusti, M and Grosso, E and Guabello, G and Guarneri, M.P and Grugni, G and Lanfranco, F and Lania, A and Lanzi, R and Larizza, L and Lenzi, A and Loche, S and ... and Italian Network on Central Hypogonadism
European Journal of Endocrinology, ISSN 0804-4643, 01/2018, Volume 178, Issue 1, pp. 23 - 32
Journal Article